Clinical Trials on HER2 Amplified Solid Tumors in United Kingdom
Total 3144 results
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Merrimack PharmaceuticalsCompletedMetastatic Breast Cancer | Her2 Amplified Solid TumorsUnited States
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Advaxis, Inc.CompletedHER2 Expressing Solid TumorsUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
Mateon TherapeuticsCancer Research UKCompleted
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
BeiGeneCompletedAdvanced Solid TumorsUnited Kingdom
-
Chugai Pharma Europe Ltd.CompletedSolid TumorsUnited Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
Genentech, Inc.CompletedSolid TumorUnited Kingdom
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Eisai LimitedCompleted
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
Jazz PharmaceuticalsBeiGene, Ltd.Active, not recruitingHER2-amplified Biliary Tract CancersUnited States, Spain, United Kingdom, Korea, Republic of, Canada, China, Italy, Chile, France
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.Completed
-
AstraZenecaCompleted
-
Leucid BioRecruitingTumor, SolidUnited Kingdom
-
University College, LondonImperial College London; Cancer Research UK; National Cancer Imaging Translational...RecruitingCancer | Tumor, SolidUnited Kingdom
-
AstraZenecaActive, not recruitingSolid TumorsUnited Kingdom, Canada
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
AstraZenecaCompletedSolid TumorsUnited States, France, United Kingdom
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Basilea PharmaceuticaCompletedSolid Organ TumorsUnited Kingdom
-
Queen Mary University of LondonRecruiting
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMetastatic Solid TumorsUnited States, Spain, United Kingdom
-
Royal Marsden NHS Foundation TrustRecruitingSolid Tumor, AdultUnited Kingdom
-
Molecular Templates, Inc.TerminatedHER2-positive Solid CancersUnited States, Australia, New Zealand
-
Eisai Inc.Completed
-
LondonPharma Ltd.Unknown
-
LondonPharma Ltd.UnknownSolid TumoursUnited Kingdom
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom